<?xml version="1.0" encoding="UTF-8"?>
<fig id="viruses-12-00470-f003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Assessment of vaccine efficiency against mouse-adapted influenza B virus in vivo and in vitro. Note: (
   <bold>A</bold>) body temperature and (
   <bold>B</bold>) body weight of; intact mice received PBS (dotted black line); vaccinated and infected intranasally with 10 MID
   <sub>50</sub> of 
   <italic>B/2017-MA</italic> strain mice (dark blue line); infected intranasally with 10 MID
   <sub>50</sub> of 
   <italic>B/2017-MA</italic> strain mice (red line); ✶ 
   <italic>p</italic> &lt; 0.05; ✶✶ 
   <italic>p</italic> &lt; 0.01; ✶✶✶ 
   <italic>p</italic> &lt; 0.001, reliability when comparing data from groups of infected mice. (
   <bold>C</bold>) On day 3 day, conjunctivitis in a mouse infected with 10 MID
   <sub>50</sub> of 
   <italic>B/2017-MA</italic> strain. (
   <bold>D</bold>) Lungs of unvaccinated and vaccinated mice on 3rd and 6th days post infection with 10 MID
   <sub>50</sub> of 
   <italic>B/2017-MA</italic> strain. (
   <bold>E</bold>) Viral titers in the lungs of unvaccinated and vaccinated mice on 3rd and 6th days post infection with 10 MID
   <sub>50</sub> of 
   <italic>B/2017-MA</italic> strain. (
   <bold>F</bold>) Cytopathic effect of Madin-Darby Canine Kidney (MDCK) cell culture on 3rd day post infection of unvaccinated and vaccinated mice with 10 MID
   <sub>50</sub> of 
   <italic>B/2017-MA</italic> strain.
  </p>
 </caption>
 <graphic xlink:href="viruses-12-00470-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
